Latest news
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 01:13:02 GMTRhythm Pharmaceuticals Announces Preliminary Data from - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 10:55:00 GMT